What is the difference between 5-Amino-1MQ and Oxyntomodulin?

5-Amino-1MQ: Inhibits NNMT enzyme, increasing SAM (S-adenosylmethionine) availability. Alters adipocyte gene expression to reduce fat cell size and may increase brown adipose tissue activity via epigenetic mechanisms. Oxyntomodulin: Dual GLP-1/glucagon receptor agonist. GLP-1 component suppresses appetite; glucagon component increases energy expenditure and fatty acid oxidation. Net effect is reduced caloric intake and elevated metabolic rate.

Is Oxyntomodulin FDA approved?

Oxyntomodulin is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

How is 5-Amino-1MQ administered in research settings?

In research settings, 5-Amino-1MQ is typically administered via the oral route. PeptideBase does not provide dosing or administration instructions.

How is Oxyntomodulin administered in research settings?

In research settings, Oxyntomodulin is typically administered via the subcutaneous or intravenous routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›5-Amino-1MQ vs Oxyntomodulin

Peptide Comparison

5-Amino-1MQ vs Oxyntomodulin

Name: 5-Amino-1MQ vs Oxyntomodulin — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Metabolic peptides.

5-Amino-1MQ

5-Amino-1-methylquinolinium

Fat LossResearch Only

49 providers listed

Full 5-Amino-1MQ profile →

Oxyntomodulin

OXM

Fat LossInvestigationalResearch Only

No providers listed yet

Full Oxyntomodulin profile →

Bottom line

Oxyntomodulin carries stronger published evidence (RCT, 11 key studies) than 5-Amino-1MQ (Animal, 1); both are research compounds.

Quick Verdict

5-Amino-1MQ

Evidence

Preclinical

Oxyntomodulin

Evidence

Established Clinical

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Oxyntomodulin
Further along in FDA review	Oxyntomodulin
Oral administration option	5-Amino-1MQ
More provider options (49 vs 0)	5-Amino-1MQ

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

5-Amino-1MQ

Oxyntomodulin

Mechanism Family

Metabolic

Half-life

—

FDA Status

unknown

investigational

Admin Routes

oral

subcutaneous, intravenous

Availability

Research Only

Providers

49 listed

None listed

Research Evidence

5-Amino-1MQ

PreclinicalAnimal · 1 key study · most recent 2022

Oxyntomodulin

Established ClinicalRCT · 11 key studies · most recent 2026

Research Citations

5-Amino-1MQ

Animal2022 · Scientific Reports

NNMT inhibitor in diet-induced obese mice: effects on body weight, body fat, and energy expenditure

Oxyntomodulin

RCT2026 · Appetite

Effects of acute moderate-intensity continuous running on circulating oxyntomodulin concentrations in healthy…

RCT2026 · Appetite

Effects of acute moderate-intensity continuous running on circulating oxyntomodulin concentrations in healthy…

RCT2026 · Appetite

Effects of acute moderate-intensity continuous running on circulating oxyntomodulin concentrations in healthy…

RCT2005 · Diabetes

Oxyntomodulin reduces energy intake and adiposity in overweight and obese subjects

+7 more

About 5-Amino-1MQ

Inhibits NNMT enzyme, increasing SAM (S-adenosylmethionine) availability. Alters adipocyte gene expression to reduce fat cell size and may increase brown adipose tissue activity via epigenetic mechanisms.

Research Areas

fat cell reductionmetabolic rateadipose tissue modulation

About Oxyntomodulin

Dual GLP-1/glucagon receptor agonist. GLP-1 component suppresses appetite; glucagon component increases energy expenditure and fatty acid oxidation. Net effect is reduced caloric intake and elevated metabolic rate.

Research Areas

appetite suppressionenergy expenditurefat oxidation

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

5-Amino-1MQ

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Oxyntomodulin

Absolute Contraindications

Personal or family history of medullary thyroid carcinoma (MTC)Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)Known hypersensitivity to the drug or excipients

Warnings & Cautions

Acute pancreatitisPregnancy (discontinue; not for use in pregnancy)Gallbladder disease / cholelithiasisDiabetic retinopathy complications (reported with GLP-1 receptor agonist use)Severe GI disease / gastroparesis / ileus riskHypoglycemia when combined with insulin or sulfonylureasAcute kidney injury secondary to volume depletion

Class-based (investigational)

Price (per mg)

5-Amino-1MQ

$5.00/mg

$2.88 – $8.00 range

20 vendors

View price index →Find providers →

Oxyntomodulin

Not enough vendor pricing yet.

Find Providers

Where to source these peptides

Providers offering

5-Amino-1MQ

49 listed

Browse directory →

Providers offering

Oxyntomodulin

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Metabolic Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 27, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). 5-Amino-1MQ vs Oxyntomodulin — Per-mg Price Comparison. Retrieved July 29, 2026, from https://peptidebase.io/peptides/compare/5-amino-1mq/oxyntomodulin

https://peptidebase.io/peptides/compare/5-amino-1mq/oxyntomodulin Methodology License Download JSON Download CSV